{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T09:43:16Z","timestamp":1789983796081,"version":"4.0.1"},"reference-count":42,"publisher":"Wiley","issue":"8","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":1476,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,10]]},"DOI":"10.1111\/j.1365-2036.2011.04808.x","type":"journal-article","created":{"date-parts":[[2011,8,17]],"date-time":"2011-08-17T07:18:26Z","timestamp":1313565506000},"page":"853-861","source":"Crossref","is-referenced-by-count":123,"title":["Randomised clinical trial: rifaximin improves health-related quality of life in cirrhotic patients with hepatic encephalopathy - a double-blind placebo-controlled study"],"prefix":"10.1111","volume":"34","author":[{"given":"A.","family":"Sanyal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Z. M.","family":"Younossi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N. M.","family":"Bass","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K. D.","family":"Mullen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Poordad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. S.","family":"Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. P.","family":"Vemuru","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Mazen Jamal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Merchant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Bortey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W. P.","family":"Forbes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2011,8,17]]},"reference":[{"key":"10.1111\/j.1365-2036.2011.04808.x-BIB1|cit1","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1053\/jhep.2002.34734","article-title":"Burden of liver disease in the United States: summary of a workshop","volume":"36","author":"Kim","year":"2002","journal-title":"Hepatology"},{"key":"10.1111\/j.1365-2036.2011.04808.x-BIB2|cit2","doi-asserted-by":"crossref","first-page":"2128","DOI":"10.1111\/j.1572-0241.2006.00723.x","article-title":"The burden of gastrointestinal and liver diseases, 2006","volume":"101","author":"Shaheen","year":"2006","journal-title":"Am J Gastroenterol"},{"key":"10.1111\/j.1365-2036.2011.04808.x-BIB3|cit3","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.apnu.2009.04.010","article-title":"Predictors of mental health, subjective burden, and rewards in family caregivers of patients with chronic liver disease","volume":"24","author":"Bolden","year":"2010","journal-title":"Arch Psychiatr Nurs"},{"key":"10.1111\/j.1365-2036.2011.04808.x-BIB4|cit4","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1002\/lt.22130","article-title":"Patients on the waiting list for liver transplantation: caregiver burden and stress","volume":"16","author":"Miyazaki","year":"2010","journal-title":"Liver Transpl"},{"key":"10.1111\/j.1365-2036.2011.04808.x-BIB5|cit5","volume-title":"Organ Procurement and Transplantation Network and the Scientific Registry of Transplant Recipients: Transplant Data 1999-2008","author":"2009 Annual Report of the U.S","year":"2009"},{"key":"10.1111\/j.1365-2036.2011.04808.x-BIB6|cit6","first-page":"227","article-title":"Overview of research on health-related quality of life in patients with chronic liver disease","volume":"65","author":"Gutteling","year":"2007","journal-title":"Neth J Med"},{"key":"10.1111\/j.1365-2036.2011.04808.x-BIB7|cit7","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/j.cgh.2009.03.013","article-title":"Health-related quality of life predicts mortality in patients with advanced chronic liver disease","volume":"7","author":"Kanwal","year":"2009","journal-title":"Clinical Gastroenterology and Hepatology"},{"key":"10.1111\/j.1365-2036.2011.04808.x-BIB8|cit8","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1002\/lt.20345","article-title":"MELD fails to measure quality of life in liver transplant candidates","volume":"11","author":"Saab","year":"2005","journal-title":"Liver Transpl"},{"key":"10.1111\/j.1365-2036.2011.04808.x-BIB9|cit9","doi-asserted-by":"crossref","first-page":"2199","DOI":"10.1111\/j.1572-0241.2001.03956.x","article-title":"Health-related quality of life in chronic liver disease: the impact of type and severity of disease","volume":"96","author":"Younossi","year":"2001","journal-title":"Am J Gastroenterol"},{"key":"10.1111\/j.1365-2036.2011.04808.x-BIB10|cit10","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1053\/jlts.2000.18499","article-title":"Impact of liver transplantation on health-related quality of life","volume":"6","author":"Younossi","year":"2000","journal-title":"Liver Transpl"},{"key":"10.1111\/j.1365-2036.2011.04808.x-BIB11|cit11","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1053\/gast.2001.21193","article-title":"Factors associated with poor health-related quality of life of patients with cirrhosis","volume":"120","author":"Marchesini","year":"2001","journal-title":"Gastroenterology"},{"key":"10.1111\/j.1365-2036.2011.04808.x-BIB12|cit12","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1023\/A:1024784327783","article-title":"Influence of hepatic encephalopathy on health-related quality of life in patients with cirrhosis","volume":"48","author":"Arguedas","year":"2003","journal-title":"Dig Dis Sci"},{"key":"10.1111\/j.1365-2036.2011.04808.x-BIB13|cit13","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1002\/hep.20840","article-title":"Quality of life in refractory ascites: transjugular intrahepatic portal-systemic shunting versus medical therapy","volume":"42","author":"Campbell","year":"2005","journal-title":"Hepatology"},{"key":"10.1111\/j.1365-2036.2011.04808.x-BIB14|cit14","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1097\/MEG.0b013e3283319975","article-title":"Quality of life in cirrhosis is related to potentially treatable factors","volume":"22","author":"Les","year":"2010","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1111\/j.1365-2036.2011.04808.x-BIB15|cit15","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1111\/j.1365-2036.2009.04061.x","article-title":"Predictors of health-related quality of life in patients with chronic liver disease","volume":"30","author":"Afendy","year":"2009","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1111\/j.1365-2036.2011.04808.x-BIB16|cit16","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/1471-230X-8-46","article-title":"Type and etiology of liver cirrhosis are not related to the presence of hepatic encephalopathy or health-related quality of life: a cross-sectional study","volume":"8","author":"Kalaitzakis","year":"2008","journal-title":"BMC gastroenterology"},{"key":"10.1111\/j.1365-2036.2011.04808.x-BIB17|cit17","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1080\/00365520600825117","article-title":"Gastrointestinal symptoms in patients with liver cirrhosis: associations with nutritional status and health-related quality of life","volume":"41","author":"Kalaitzakis","year":"2006","journal-title":"Scand J Gastroenterol"},{"key":"10.1111\/j.1365-2036.2011.04808.x-BIB18|cit18","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1002\/hep.21760","article-title":"Lactulose treatment for hepatic encephalopathy, gastrointestinal symptoms, and health-related quality of life","volume":"46","author":"Kalaitzakis","year":"2007","journal-title":"Hepatology"},{"key":"10.1111\/j.1365-2036.2011.04808.x-BIB19|cit19","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1002\/hep.21533","article-title":"Lactulose improves cognitive functions and health-related quality of life in patients with cirrhosis who have minimal hepatic encephalopathy","volume":"45","author":"Prasad","year":"2007","journal-title":"Hepatology"},{"key":"10.1111\/j.1365-2036.2011.04808.x-BIB20|cit20","doi-asserted-by":"crossref","first-page":"3003","DOI":"10.3748\/wjg.v13.i21.3003","article-title":"Assessment of health-related quality of life in Chinese patients with minimal hepatic encephalopathy","volume":"13","author":"Bao","year":"2007","journal-title":"World J Gastroenterol"},{"key":"10.1111\/j.1365-2036.2011.04808.x-BIB21|cit21","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1097\/MEG.0b013e328333df0f","article-title":"Extrapyramidal signs predict the development of overt hepatic encephalopathy in patients with liver cirrhosis","volume":"22","author":"Company","year":"2010","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1111\/j.1365-2036.2011.04808.x-BIB22|cit22","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1053\/jhep.2002.31250","article-title":"Hepatic encephalopathy-definition, nomenclature, diagnosis, and quantification: final report of the working party at the 11th World Congresses of Gastroenterology, Vienna, 1998","volume":"35","author":"Ferenci","year":"2002","journal-title":"Hepatology"},{"key":"10.1111\/j.1365-2036.2011.04808.x-BIB23|cit23","first-page":"1365","article-title":"Hepatic encephalopathy as a predictor of survival in patients with endstage liver disease","volume":"29","author":"Stewart","year":"2009","journal-title":"Liver Int"},{"key":"10.1111\/j.1365-2036.2011.04808.x-BIB24|cit24","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1016\/S0168-8278(99)80144-5","article-title":"Prognostic significance of hepatic encephalopathy in patients with cirrhosis","volume":"30","author":"Bustamante","year":"1999","journal-title":"J Hepatol"},{"key":"10.1111\/j.1365-2036.2011.04808.x-BIB25|cit25","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1007\/s10620-006-9442-4","article-title":"Hospitalizations during the use of rifaximin versus lactulose for the treatment of hepatic encephalopathy","volume":"52","author":"Leevy","year":"2007","journal-title":"Dig Dis Sci"},{"issue":"s1","key":"10.1111\/j.1365-2036.2011.04808.x-BIB26|cit26","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1746-6342.2006.03215.x","article-title":"Review article: the burden of hepatic encephalopathy","volume":"25","author":"Poordad","year":"2007","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1111\/j.1365-2036.2011.04808.x-BIB27|cit27","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1038\/ajg.2009.7","article-title":"The effect of fatigue on driving skills in patients with hepatic encephalopathy","volume":"104","author":"Bajaj","year":"2009","journal-title":"Am J Gastroenterol"},{"key":"10.1111\/j.1365-2036.2011.04808.x-BIB28|cit28","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/ajg.2010.455","article-title":"Rifaximin improves psychometric performance and health-related quality of life in patients with minimal hepatic encephalopathy (The RIME Trial)","volume":"106","author":"Sidhu","year":"2011","journal-title":"Am J Gastroenterol"},{"key":"10.1111\/j.1365-2036.2011.04808.x-BIB29|cit29","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1111\/j.1365-2036.2010.04257.x","article-title":"Predictors of the recurrence of hepatic encephalopathy in lactulose-treated patients","volume":"31","author":"Bajaj","year":"2010","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1111\/j.1365-2036.2011.04808.x-BIB30|cit30","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1136\/gut.45.2.295","article-title":"Development of a disease specific questionnaire to measure health related quality of life in patients with chronic liver disease","volume":"45","author":"Younossi","year":"1999","journal-title":"Gut"},{"key":"10.1111\/j.1365-2036.2011.04808.x-BIB31|cit31","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1056\/NEJMoa0907893","article-title":"Rifaximin treatment in hepatic encephalopathy","volume":"362","author":"Bass","year":"2010","journal-title":"N Engl J Med"},{"issue":"4 Pt 1","key":"10.1111\/j.1365-2036.2011.04808.x-BIB32|cit32","first-page":"573","article-title":"Comparison of lactulose and neomycin in the treatment of chronic portal-systemic encephalopathy","volume":"72","author":"Conn","year":"1977","journal-title":"A double blind controlled trial. Gastroenterology"},{"key":"10.1111\/j.1365-2036.2011.04808.x-BIB33|cit33","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1053\/jlts.2002.31340","article-title":"Model for end-stage liver disease and Child-Turcotte-Pugh score as predictors of pretransplantation disease severity, posttransplantation outcome, and resource utilization in United Network for Organ Sharing status 2A patients","volume":"8","author":"Brown","year":"2002","journal-title":"Liver Transpl"},{"key":"10.1111\/j.1365-2036.2011.04808.x-BIB34|cit34","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1097\/00042737-200012020-00012","article-title":"Evaluation of the efficacy and safety of rifaximin in the treatment of hepatic encephalopathy: a double-blind, randomized, dose-finding multi-centre study","volume":"12","author":"Williams","year":"2000","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1111\/j.1365-2036.2011.04808.x-BIB35|cit35","first-page":"57","article-title":"Rifaximin in the treatment of hepatic encephalopathy","volume":"4","author":"Giacomo","year":"1993","journal-title":"European Journal of Clinical Research"},{"key":"10.1111\/j.1365-2036.2011.04808.x-BIB36|cit36","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1056\/NEJMoa0907893","article-title":"Rifaximin treatment in hepatic encephalopathy","volume":"362","author":"Bass","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1365-2036.2011.04808.x-BIB37|cit37","first-page":"328A","article-title":"Long-term administration of rifaximin improves the prognosis of patients with alcohol-related deconpensated cirrhosis: a case-control study","volume":"52","author":"Vlachogiannakos","year":"2010","journal-title":"Hepatology"},{"key":"10.1111\/j.1365-2036.2011.04808.x-BIB38|cit38","doi-asserted-by":"crossref","first-page":"S-903","DOI":"10.1016\/S0016-5085(11)63745-1","article-title":"Rifaximin prevents spontaneous bacterial peritonitis and improves transplant free survival in patients with liver cirrhosis","volume":"140","author":"Hanouneh","year":"2011","journal-title":"Gastroenterology"},{"key":"10.1111\/j.1365-2036.2011.04808.x-BIB39|cit39","doi-asserted-by":"crossref","first-page":"2705","DOI":"10.1038\/ajg.2010.364","article-title":"Thrombocytopenia associated with chronic liver disease: effects of rifaximin on platelet count","volume":"105","author":"Kalambokis","year":"2010","journal-title":"Am J Gastroenterol"},{"key":"10.1111\/j.1365-2036.2011.04808.x-BIB40|cit40","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1111\/j.1365-2036.2009.03958.x","article-title":"Intestinal decontamination improves liver haemodynamics in patients with alcohol-related decompensated cirrhosis","volume":"29","author":"Vlachogiannakos","year":"2009","journal-title":"Aliment Pharmacol Ther"},{"issue":"s1","key":"10.1111\/j.1365-2036.2011.04808.x-BIB41|cit41","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/j.1746-6342.2006.03217.x","article-title":"Review article: bacterial flora and pathogenesis in hepatic encephalopathy","volume":"25","author":"Williams","year":"2007","journal-title":"Alimentary Pharmacol Ther"},{"key":"10.1111\/j.1365-2036.2011.04808.x-BIB42|cit42","doi-asserted-by":"crossref","first-page":"4543","DOI":"10.1016\/j.transproceed.2010.09.173","article-title":"Rifaximin for the treatment of hepatic encephalopathy","volume":"42","author":"Mantry","year":"2010","journal-title":"Transplant Proc"}],"container-title":["Alimentary Pharmacology & Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2036.2011.04808.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1365-2036.2011.04808.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,10]],"date-time":"2024-04-10T02:17:53Z","timestamp":1712715473000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2036.2011.04808.x"}},"subtitle":["Randomised clinical trial: rifaximin improves HRQL in cirrhotic patients with hepatic encephalopathy"],"short-title":[],"issued":{"date-parts":[[2011,8,17]]},"references-count":42,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2011,10]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1365-2036.2011.04808.x","relation":{},"ISSN":["0269-2813"],"issn-type":[{"value":"0269-2813","type":"print"}],"subject":[],"published":{"date-parts":[[2011,8,17]]}}}